124 related articles for article (PubMed ID: 38237100)
1. Detection of Copy-Number Variation in Circulating Cell-Free DNA in Patients With Uveal Melanoma.
Sato T; Montazeri K; Gragoudas ES; Lane AM; Aronow MB; Cohen JV; Boland GM; Banks E; Kachulis C; Fleharty M; Cibulskis C; Lawless A; Adalsteinsson VA; Sullivan RJ; Kim IK
JCO Precis Oncol; 2024 Jan; 8():e2300368. PubMed ID: 38237100
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Circulating Tumor DNA as a Liquid Biomarker in Uveal Melanoma.
de Bruyn DP; van Poppelen NM; Brands T; van den Boom SC; Eikenboom E; Wagner A; van Veghel-Plandsoen MM; Geeven G; Beverloo B; van Rij CM; Verdijk RM; Naus NC; Bagger MM; Kiilgaard JF; de Klein A; Brosens E; Kiliç E
Invest Ophthalmol Vis Sci; 2024 Feb; 65(2):11. PubMed ID: 38319670
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumor DNA tracking through driver mutations as a liquid biopsy-based biomarker for uveal melanoma.
Bustamante P; Tsering T; Coblentz J; Mastromonaco C; Abdouh M; Fonseca C; Proença RP; Blanchard N; Dugé CL; Andujar RAS; Youhnovska E; Burnier MN; Callejo SA; Burnier JV
J Exp Clin Cancer Res; 2021 Jun; 40(1):196. PubMed ID: 34134723
[TBL] [Abstract][Full Text] [Related]
4. Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis.
van den Bosch T; van Beek JG; Vaarwater J; Verdijk RM; Naus NC; Paridaens D; de Klein A; Kiliç E
Invest Ophthalmol Vis Sci; 2012 May; 53(6):2668-74. PubMed ID: 22427574
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment.
Sogbe M; Bilbao I; Marchese FP; Zazpe J; De Vito A; Pozuelo M; D'Avola D; Iñarrairaegui M; Berasain C; Arechederra M; Argemi J; Sangro B
Clin Mol Hepatol; 2024 Apr; 30(2):177-190. PubMed ID: 38163441
[TBL] [Abstract][Full Text] [Related]
6. The Prognostic Value of AJCC Staging in Uveal Melanoma Is Enhanced by Adding Chromosome 3 and 8q Status.
Dogrusöz M; Bagger M; van Duinen SG; Kroes WG; Ruivenkamp CA; Böhringer S; Andersen KK; Luyten GP; Kiilgaard JF; Jager MJ
Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):833-842. PubMed ID: 28159971
[TBL] [Abstract][Full Text] [Related]
7. Personalized Prognosis of Uveal Melanoma Based on Cytogenetic Profile in 1059 Patients over an 8-Year Period: The 2017 Harry S. Gradle Lecture.
Shields CL; Say EAT; Hasanreisoglu M; Saktanasate J; Lawson BM; Landy JE; Badami AU; Sivalingam MD; Hauschild AJ; House RJ; Daitch ZE; Mashayekhi A; Shields JA; Ganguly A
Ophthalmology; 2017 Oct; 124(10):1523-1531. PubMed ID: 28495150
[TBL] [Abstract][Full Text] [Related]
8. Evolutionary Routes in Metastatic Uveal Melanomas Depend on
Rodrigues M; Mobuchon L; Houy A; Alsafadi S; Baulande S; Mariani O; Marande B; Ait Rais K; Van der Kooij MK; Kapiteijn E; Gassama S; Gardrat S; Barnhill RL; Servois V; Dendale R; Putterman M; Tick S; Piperno-Neumann S; Cassoux N; Pierron G; Waterfall JJ; Roman-Roman S; Mariani P; Stern MH
Clin Cancer Res; 2019 Sep; 25(18):5513-5524. PubMed ID: 31227496
[TBL] [Abstract][Full Text] [Related]
9. Digital PCR validates 8q dosage as prognostic tool in uveal melanoma.
Versluis M; de Lange MJ; van Pelt SI; Ruivenkamp CA; Kroes WG; Cao J; Jager MJ; Luyten GP; van der Velden PA
PLoS One; 2015; 10(3):e0116371. PubMed ID: 25764247
[TBL] [Abstract][Full Text] [Related]
10. Improved Uveal Melanoma Copy Number Subtypes Including an Ultra-High-Risk Group.
Lalonde E; Ewens K; Richards-Yutz J; Ebrahimzedeh J; Terai M; Gonsalves CF; Sato T; Shields CL; Ganguly A
Ophthalmol Sci; 2022 Jun; 2(2):100121. PubMed ID: 36249692
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of extraocular extension in relation to monosomy 3 and gain of chromosome 8q in uveal melanoma.
van Beek JG; Koopmans AE; Vaarwater J; de Rooi JJ; Paridaens D; Naus NC; de Klein A; Verdijk RM; Kiliç E
Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1284-91. PubMed ID: 24508790
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma.
Patrone S; Maric I; Rutigliani M; Lanza F; Puntoni M; Banelli B; Rancati S; Angelini G; Amaro A; Ligorio P; Defferrari C; Castagnetta M; Bandelloni R; Mosci C; DeCensi A; Romani M; Pfeffer U; Viaggi S; Coviello DA
Genes Chromosomes Cancer; 2018 Aug; 57(8):387-400. PubMed ID: 29689622
[TBL] [Abstract][Full Text] [Related]
13. Replacement and desmoplastic histopathological growth patterns: A pilot study of prediction of outcome in patients with uveal melanoma liver metastases.
Barnhill R; Vermeulen P; Daelemans S; van Dam PJ; Roman-Roman S; Servois V; Hurbain I; Gardrat S; Raposa G; Nicolas A; Dendale R; Pierron G; Desjardins L; Cassoux N; Piperno-Neumann S; Mariani P; Lugassy C
J Pathol Clin Res; 2018 Oct; 4(4):227-240. PubMed ID: 29917326
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Factors Five Years After Enucleation for Uveal Melanoma.
Dogrusöz M; Brouwer NJ; de Geus SJR; Ly LV; Böhringer S; van Duinen SG; Kroes WGM; van der Velden PA; Haasnoot GW; Marinkovic M; Luyten GPM; Kivelä TT; Jager MJ
Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):31. PubMed ID: 32186672
[TBL] [Abstract][Full Text] [Related]
15. The Cancer Genome Atlas for uveal melanoma is predictive of patient outcomes.
Bas Z; Grant-Kels JM; Shields CL
Clin Dermatol; 2024; 42(1):56-61. PubMed ID: 37890680
[TBL] [Abstract][Full Text] [Related]
16. Whole-genome copy-number analysis identifies new leads for chromosomal aberrations involved in the oncogenesis and metastastic behavior of uveal melanomas.
van Engen-van Grunsven AC; Baar MP; Pfundt R; Rijntjes J; Küsters-Vandevelde HV; Delbecq AL; Keunen JE; Klevering JB; Wesseling P; Blokx WA; Groenen PJ
Melanoma Res; 2015 Jun; 25(3):200-9. PubMed ID: 25756553
[TBL] [Abstract][Full Text] [Related]
17. 8q Gain Has No Additional Predictive Value in
Nguyen JQN; Drabarek W; Vaarwater J; Yavuzyigitoglu S; Verdijk RM; Paridaens D; Naus NC; de Klein A; Brosens E; Kiliç E;
Ophthalmol Sci; 2024; 4(2):100413. PubMed ID: 38187129
[TBL] [Abstract][Full Text] [Related]
18. High-Resolution Array CGH Analysis Identifies Regional Deletions and Amplifications of Chromosome 8 in Uveal Melanoma.
Hammond DW; Al-Shammari NS; Danson S; Jacques R; Rennie IG; Sisley K
Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):3460-6. PubMed ID: 26030101
[TBL] [Abstract][Full Text] [Related]
19. Low-Pass Whole-Genome Sequencing as a Method of Determining Copy Number Variations in Uveal Melanoma Tissue Samples.
Beasley AB; Bentel J; Allcock RJN; Vermeulen T; Calapre L; Isaacs T; Ziman MR; Chen FK; Gray ES
J Mol Diagn; 2020 Mar; 22(3):429-434. PubMed ID: 31978561
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide profiling of circulating tumor DNA depicts landscape of copy number alterations in pancreatic cancer with liver metastasis.
Wei T; Zhang J; Li J; Chen Q; Zhi X; Tao W; Ma J; Yang J; Lou Y; Ma T; Li X; Zhang Q; Chen W; Que R; Gao S; Bai X; Liang T
Mol Oncol; 2020 Sep; 14(9):1966-1977. PubMed ID: 32593194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
